Executive Overview
Senior financial executive with extensive leadership experience in multiple industries and with both public and private companies. Currently EVP and interim CFO of IQVIA, an S&P500 company and leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Board member and chairman of audit committee of Atotech Ltd., a private equity owned global leader in surface finish solutions. Served for 5+ years as SVP and CFO of IMS Health, a $3.2B provider of information, services, and technology to the global healthcare industry. Previously served in various senior roles with United Technologies, a $60B global provider of high technology products and services to the building and aerospace industries. Expertise in general financial management, financial planning/analysis, investor relations, mergers and acquisitions, corporate strategy, treasury, capital markets, and manufacturing and service operations. Experience includes: Private/public company CFO experience (led IMS IPO in 2014) and currently EVP and Interim CFO of IQVIA. Executed $25B merger of equals with Quintiles Transnational in 2016 CFO of $15B global manufacturing division of public company. Substantial international experience, including Paris-based EMEA region CFO role Extensive interaction with security analyst and banking communities through - CFO of IMS Health - leadership of UTC investor relations - leadership of UTC global strategy and development - capital markets management in UTC Treasury Strong FP&A and operations finance background in manufacturing and service businesses at both the divisional and corporate levels Board member and Audit Committee chairman for publicly traded company in which UTC owned a non-controlling interest. Chairman of Board of Q-Squared Solutions, a joint venture between IQVIA Inc. and Quest Diagnostics, the second largest global provider of laboratory services for clinical trials. Specialties: General financial management Financial planning and analysis Investor relations Mergers and acquisitions Strategy Capital markets Treasury International business Manufacturing and service operations finance
Career Timeline
- GoodRxCurrentNov 2024–Present· 1 yr 10 mos
- Board Director and Audit Committee ChairCurrentNov 2024–Present
- IQVIACurrentOct 2016–Present· 9 yrs 11 mos
- Executive Vice President, Chief Financial OfficerCurrentJul 2020–Present
- Senior Advisor to CEOOct 2016–Jul 2020
- Mar 2020–Aug 2022· 2 yrs 5 mos
- Board Director and Audit Committee ChairMar 2020–Aug 2022
- Jul 2011–Oct 2016· 5 yrs 3 mos
- Senior VP and Chief Financial OfficerJul 2011–Oct 2016
- May 2008–Apr 2011· 2 yrs 11 mos
- Vice President, Business DevelopmentJun 2009–Apr 2011
- VP, Operations Planning & Analysis, Commercial CompaniesMay 2008–Jun 2009
- Jun 2005–May 2008· 2 yrs 11 mos
- VP and Chief Financial OfficerJun 2005–May 2008
- Apr 2004–Jun 2005· 1 yr 2 mos
- VP, Financial Planning & AnalysisApr 2004–Jun 2005
- Oct 2000–Apr 2004· 3 yrs 6 mos
- Director, Financial Planning & AnalysisOct 2000–Apr 2004
- Apr 1999–Oct 2000· 1 yr 6 mos
- VP and CFO, Europe, Middle East, and AfricaApr 1999–Oct 2000
- Jun 1996–Apr 1999· 2 yrs 10 mos
- Director, Investor RelationsJun 1996–Apr 1999
Education
MBA
Finance
University of ChicagoBS
Economics
Alfred Lerner College of Business & Economics at University of Delaware